Clinical Trial Update: Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficiency and security of nivolumab therapy in obese individuals with COVID-19 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection
• Obesity

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Obesity, COVID-19 Infection | Phase 2 | Status: UNKNOWN